Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria

The lack of therapeutic options to treat infections caused by multidrug-resistant (MDR) pathogens, especially Gram-negative bacteria, is apparent. Therefore, it is imperative to develop new strategies to address the problem of antimicrobial resistance. Repurposing non-antibiotic commercial drugs for...

Descripción completa

Detalles Bibliográficos
Autores principales: Domalaon, Ronald, Ammeter, Derek, Brizuela, Marc, Gorityala, Bala Kishan, Zhanel, George G., Schweizer, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636613/
https://www.ncbi.nlm.nih.gov/pubmed/31354660
http://dx.doi.org/10.3389/fmicb.2019.01556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636613/
https://www.ncbi.nlm.nih.gov/pubmed/31354660
http://dx.doi.org/10.3389/fmicb.2019.01556

Ejemplares similares